1. Home
  2. ATCH vs BDSX Comparison

ATCH vs BDSX Comparison

Compare ATCH & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATCH
  • BDSX
  • Stock Information
  • Founded
  • ATCH 2022
  • BDSX 2005
  • Country
  • ATCH United States
  • BDSX United States
  • Employees
  • ATCH N/A
  • BDSX N/A
  • Industry
  • ATCH
  • BDSX Precision Instruments
  • Sector
  • ATCH
  • BDSX Health Care
  • Exchange
  • ATCH Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • ATCH 46.1M
  • BDSX 53.0M
  • IPO Year
  • ATCH N/A
  • BDSX 2020
  • Fundamental
  • Price
  • ATCH $0.38
  • BDSX $6.83
  • Analyst Decision
  • ATCH
  • BDSX Strong Buy
  • Analyst Count
  • ATCH 0
  • BDSX 5
  • Target Price
  • ATCH N/A
  • BDSX $32.50
  • AVG Volume (30 Days)
  • ATCH 46.4M
  • BDSX 280.7K
  • Earning Date
  • ATCH 11-17-2025
  • BDSX 11-03-2025
  • Dividend Yield
  • ATCH N/A
  • BDSX N/A
  • EPS Growth
  • ATCH N/A
  • BDSX N/A
  • EPS
  • ATCH 0.96
  • BDSX N/A
  • Revenue
  • ATCH $10,856,612.00
  • BDSX $76,556,000.00
  • Revenue This Year
  • ATCH N/A
  • BDSX $18.78
  • Revenue Next Year
  • ATCH N/A
  • BDSX $26.42
  • P/E Ratio
  • ATCH $0.40
  • BDSX N/A
  • Revenue Growth
  • ATCH 171.31
  • BDSX 25.70
  • 52 Week Low
  • ATCH $0.14
  • BDSX $3.44
  • 52 Week High
  • ATCH $26.94
  • BDSX $34.39
  • Technical
  • Relative Strength Index (RSI)
  • ATCH 46.68
  • BDSX 54.95
  • Support Level
  • ATCH $0.39
  • BDSX $6.22
  • Resistance Level
  • ATCH $0.54
  • BDSX $7.00
  • Average True Range (ATR)
  • ATCH 0.04
  • BDSX 0.66
  • MACD
  • ATCH 0.00
  • BDSX -0.19
  • Stochastic Oscillator
  • ATCH 20.17
  • BDSX 50.36

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: